loadpatents
name:-0.038938999176025
name:-0.0091159343719482
name:-0.01538610458374
Forman; Stephen J. Patent Filings

Forman; Stephen J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Forman; Stephen J..The latest application filed is for "chimeric antigen receptors targeting her2".

Company Profile
17.6.37
  • Forman; Stephen J. - Duarte CA
  • FORMAN; Stephen J. - San Marino CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Chimeric Antigen Receptors Targeting Her2
App 20220265796 - Priceman; Saul J. ;   et al.
2022-08-25
Chimeric Antigen Receptors Containing A Chlorotoxin Domain
App 20220177528 - Barish; Michael ;   et al.
2022-06-09
Methods For Manufacturing T Cells Expressing Of Chimeric Antigen Receptors And Other Receptors
App 20220145252 - Brown; Christine E. ;   et al.
2022-05-12
Baff-r/cd19 Targeted Chimeric Antigen Receptor-modified T Cells And Use Thereof
App 20220125840 - Qin; Hong ;   et al.
2022-04-28
Combination Therapy Comprising Cancer-targeted Car-t Cells And A Method Of Using Same For A Treatment For Cancer
App 20220072043 - Niss; Knut ;   et al.
2022-03-10
Chimeric antigen receptors containing a chlorotoxin domain
Grant 11,230,577 - Barish , et al. January 25, 2
2022-01-25
Bi-specific Targeted Chimeric Antigen Receptor T Cells
App 20210386840 - Wang; Xiuli ;   et al.
2021-12-16
Chimeric antigen receptors targeting HER2
Grant 11,197,919 - Priceman , et al. December 14, 2
2021-12-14
Oxabicycloheptanes For Enhancing Car T Cell Function
App 20210379106 - KOVACH; John S. ;   et al.
2021-12-09
Tag72 Targeted Chimeric Antigen Receptor Modified T Cells For Treatment Of Tag72-positive Tumors
App 20210308184 - Priceman; Saul J. ;   et al.
2021-10-07
Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous System
App 20210244761 - Badie; Behnam ;   et al.
2021-08-12
Cs1 Targeted Chimeric Antigen Receptor-modified T Cells
App 20210170001 - Wang; Xiuli ;   et al.
2021-06-10
Methods For Preparing Cells For Adoptive T Cell Therapy
App 20210102165 - Forman; Stephen J. ;   et al.
2021-04-08
Chimeric Antigen Receptors And Methods For Reducing Toxicity
App 20210046155 - Wang; Xiuli ;   et al.
2021-02-18
Treatment Of Cns Lymphoma And Systemic Lymphoma With Intracerebroventricularly Administered Cd19 Car
App 20200345823 - Wang; Xiuli ;   et al.
2020-11-05
CS1 targeted chimeric antigen receptor-modified T cells
Grant 10,821,161 - Wang , et al. November 3, 2
2020-11-03
COSTIMULATORY CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING IL13R-alpha-2
App 20200318069 - Brown; Christine E. ;   et al.
2020-10-08
Chimeric Antigen Receptors Targeted To Psca
App 20200308300 - Priceman; Saul J. ;   et al.
2020-10-01
Deterministic Mechanoporation For Cell Engineering
App 20200289568 - Rao; Masaru P. ;   et al.
2020-09-17
CD123-Specific Chimeric Antigen Receptor Redirected T Cells and Methods of Their Use
App 20200254023 - Kind Code
2020-08-13
Methods Of Treatment Using Decitabine And A Cd123-targeted Therapy
App 20200222462 - Cohen; Pam ;   et al.
2020-07-16
Oncolytic Virus Expressing A Car T Cell Target And Uses Thereof
App 20200215132 - Fong; Yuman ;   et al.
2020-07-09
Cs1 Targeted Chimeric Antigen Receptor-modified T Cells For Treatment Of Al Amyloidosis
App 20200188432 - Wang; Xiuli ;   et al.
2020-06-18
Costimulatory chimeric antigen receptor T cells targeting IL13R.alpha.2
Grant 10,676,717 - Brown , et al.
2020-06-09
CD123-specific chimeric antigen receptor redirected T cells and methods of their use
Grant 10,660,916 - Forman , et al.
2020-05-26
Methods For Manufacturing T Cells Expressing Of Chimeric Antigen Receptors And Other Receptors
App 20200095547 - Alizadeh; Darya ;   et al.
2020-03-26
CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE
App 20200040096 - Forman; Stephen J. ;   et al.
2020-02-06
Chimeric Antigen Receptors Containing A Chlorotoxin Domain
App 20190389917 - Barish; Michael ;   et al.
2019-12-26
T Cells For Expression Of Chimeric Antigen Receptors And Other Receptors
App 20190175648 - Brown; Christine E. ;   et al.
2019-06-13
Chimeric Antigen Receptors Targeting Her2
App 20180326032 - Priceman; Saul J. ;   et al.
2018-11-15
Methods For Preparing Cells For Adoptive T Cell Therapy
App 20180320133 - Forman; Stephen J. ;   et al.
2018-11-08
Costimulatory Chimeric Antigen Receptor T Cells Targeting IL13R-alpha-2
App 20180265844 - Brown; Christine E. ;   et al.
2018-09-20
Bi-specific Targeted Chimeric Antigen Receptor T Cells
App 20180214527 - Wang; Xiuli ;   et al.
2018-08-02
Costimulatory chimeric antigen receptor T cells targeting IL13R.alpha.2
Grant 9,914,909 - Brown , et al. March 13, 2
2018-03-13
Cs1 Targeted Chimeric Antigen Receptor-modified T Cells
App 20170360910 - Wang; Xiuli ;   et al.
2017-12-21
CD123-Specific Chimeric Antigen Receptor Redirected T Cells and Methods of Their Use
App 20170260277 - Forman; Stephen J. ;   et al.
2017-09-14
Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous System
App 20170224733 - Badie; Behnam ;   et al.
2017-08-10
Costimulatory Chimeric Antigen Receptor T Cells Targeting IL13Rx2
App 20160340649 - Brown; Christine E. ;   et al.
2016-11-24
CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE
App 20160333108 - Forman; Stephen J. ;   et al.
2016-11-17
Company Registrations
SEC0001676461Forman Stephen J.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed